Close

Help us reach $1,000,000! Match My Donation

Donna FernandezLung Cancer |  Diagnosed 2012

Hope ... there is always hope.

Donna's Story

Living with stage 4 lung cancer since 2012. Treated with nivolumab in a clinical trial. Learn more about my story below.

Question and Answers

How and when did you first learn you had cancer?

I was first diagnosed with lung cancer in 2012. I hadn’t been to the doctor for about 10 years, and I kept gaining weight and didn’t know why. I finally went to the doctor because I thought something was wrong with my thyroid. During the exam, she felt a little knot on my collar bone, so she sent me to get a CT scan that day. And sure enough, the CT scan showed that there was a problem, but it wasn’t what I’d thought.

Within three weeks, I went from having no clue whatsoever that I was sick—I was working full time and doing dog agility several nights a week and every weekend—to seeing an oncologist and learning that I had stage 4 lung cancer.

How did you learn about immunotherapy and why did you decide to do it?

When my oncologist took me off of the treatments, the tumors started growing again by leaps and bounds. They didn’t spread, but they grew back to the size they were before.

At that point, my oncologist said that I could start a new chemo regimen (I had been so sick from the first treatment that thinking about going through it again was not very encouraging) or he said I could go into a clinical trial of an immunotherapy drug called Opdivo. We went right into the clinical trial.

The main side effect I have, funnily enough, is a problem with my thyroid. I just take a little pill to treat that every day. I’m also a little bit more fatigued the day of and the day after a treatment. If I don’t have anything to do, I’m more willing than normal to just veg on the couch. But if I do have something to do, I’m able to do it.

What was treatment like? Did you have any side effects?

When I entered the clinical trial, I really didn’t have much hope for it to help me personally. I was really doing it because I thought my time on earth was probably pretty limited, and that I might be able to help future generations.

But it worked from the get go. I had to have CT scans every six weeks. The first scan showed that the tumors were completely stable. And they have been completely stable since then.

When the doctor told us that I had stage 4 lung cancer, he asked if I had any questions. My question to him was whether I could keep playing agility. So that just shows a little bit about what our attitude was. It was “life continues until it doesn’t.”

How did immunotherapy compare to other treatments you may have received, if any?

I started out with a combination of chemotherapy, Alimta, and Avastin, which I had four cycles of. Nextmy oncologist put me on Avastin only for four more treatments. And the cancer responded. The tumors shrank. But my body didn’t react well. I was horribly sick from it.
 

Are there things that surprise you about the cancer experience?

I have two dogs. One is an American Eskimo, named Cotton. She is very opinionated, and very smart. I also have a Sheltie named Barney. They’re so much fun. And I’ve met some incredible people by doing agility. Before, I was one of those people who went to work, and came home; went to work, came home. I really didn’t have many outside interests. But agility changed that. All of a sudden I was hardly ever at home. I’m not an athlete at all, but it is one fun sport.

What would you want another patient to know about immunotherapy or about participating in a clinical trial?

Opdivo has let me live my life exactly how I want to. People talk about a “new normal” after cancer, but I don’t have a new normal. I’m still living my old normal.

We're Stronger Together

Provide guidance and encouragement to others going through their journey with cancer immunotherapy treatment.

Share Your Story
Let's spread the word about Immunotherapy! Click to share this page with your community.
Copy Link

*Immunotherapy results may vary from patient to patient.

Patient education information supported by a charitable donation from Bristol-Myers Squibb Company.
Top